documents: FDA-2022-D-0697-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2022-D-0697-0002 | FDA | FDA-2022-D-0697 | Sameness Evaluations in an Abbreviated New Drug Application—Active Ingredients; Draft Guidance for Industry; Availability | Other | Guidance | 2022-11-09T05:00:00Z | 2022 | 11 | 2022-11-09T05:00:00Z | 2023-01-10T04:59:59Z | 2024-11-07T00:43:32Z | 1 | 0 | 090000648549d3b7 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref